Evelo Biosciences Stock Five Year Return
Evelo Biosciences fundamentals help investors to digest information that contributes to Evelo Biosciences' financial success or failures. It also enables traders to predict the movement of Evelo Pink Sheet. The fundamental analysis module provides a way to measure Evelo Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Evelo Biosciences pink sheet.
Evelo |
Evelo Biosciences Company Five Year Return Analysis
Evelo Biosciences' Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
CompetitionAccording to the company disclosure, Evelo Biosciences has a Five Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Evelo Five Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Evelo Biosciences' direct or indirect competition against its Five Year Return to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Evelo Biosciences could also be used in its relative valuation, which is a method of valuing Evelo Biosciences by comparing valuation metrics of similar companies.Evelo Biosciences is currently under evaluation in five year return category among its peers.
Evelo Fundamentals
Return On Equity | -62.33 | ||||
Return On Asset | -0.83 | ||||
Current Valuation | 23.69 M | ||||
Shares Outstanding | 18.93 M | ||||
Shares Owned By Insiders | 0.23 % | ||||
Shares Owned By Institutions | 83.13 % | ||||
Number Of Shares Shorted | 430.1 K | ||||
Price To Earning | (4.19) X | ||||
Price To Book | 3.51 X | ||||
EBITDA | (108.41 M) | ||||
Net Income | (114.53 M) | ||||
Cash And Equivalents | 92.01 M | ||||
Cash Per Share | 0.85 X | ||||
Total Debt | 51.14 M | ||||
Debt To Equity | 1.55 % | ||||
Current Ratio | 4.53 X | ||||
Book Value Per Share | (1.42) X | ||||
Cash Flow From Operations | (101.23 M) | ||||
Short Ratio | 0.42 X | ||||
Earnings Per Share | (15.64) X | ||||
Target Price | 10.0 | ||||
Number Of Employees | 66 | ||||
Beta | 1.74 | ||||
Market Capitalization | 7 M | ||||
Total Asset | 64.44 M | ||||
Retained Earnings | (529.22 M) | ||||
Working Capital | 39.18 M | ||||
Current Asset | 49.29 M | ||||
Current Liabilities | 4.32 M | ||||
Z Score | -16.24 | ||||
Net Asset | 64.44 M |
Pair Trading with Evelo Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evelo Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evelo Biosciences will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to McCormick Company could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace McCormick Company when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back McCormick Company - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling McCormick Company Incorporated to buy it.
The correlation of McCormick Company is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as McCormick Company moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if McCormick Company moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for McCormick Company can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Evelo Pink Sheet
If you are still planning to invest in Evelo Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Evelo Biosciences' history and understand the potential risks before investing.
Commodity Directory Find actively traded commodities issued by global exchanges | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |